Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HP1V3cp45) among susceptible infants and toddlers

被引:25
作者
Madhi, SA
Cutland, C
Zhu, YW
Hackell, JG
Newman, F
Blackburn, N
Murphy, BR
Belshe, RB
Karron, RA
Deatly, AM
Gruber, WC
Bernstein, DI
Wright, PF
机构
[1] Univ Witwatersrand, MRC, Resp & Meningeal Pathogens Res Unit, ZA-2050 Johannesburg, South Africa
[2] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA
[3] Wyeth Res, Viral Vaccines, Pearl River, NY USA
[4] St Louis Univ, Div Infect Dis & Immunol, St Louis, MO 63103 USA
[5] Natl Inst Communicable Dis, Johannesburg, South Africa
[6] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
[7] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA
[8] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA
[9] Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA
关键词
parainfluenza virus type 3; vaccine; live-attenuated; transmissibility; immunogenicity; safety;
D O I
10.1016/j.vaccine.2005.12.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: This study examined the transmissibility between young children of an intranasally administered live attenuated human parainfluenza virus type 3 (HPIV3)-cp45 vaccine candidate. Methods: Eighty subjects were enrolled in playgroups among whom there was at least one infected vaccinee in close contact with a seronegative placebo recipient over 21 days without a confounding infection with wtHPIV3. Following vaccination viral cultures were obtained on nine occasions to detect shedding and transmission of HPIV3cp45. Serum antibody titers were measured before and 7 weeks after vaccination. Results: No child fulfilled the criteria for transmission of HPIV3cp45 giving a risk of transmission of 0.04 (95% Cl 0.01-0.19), hence establishing that HPIV3cp45 is less infectious than wtHPIV3 and risk of transmission is not a limitation to further clinical development of this vaccine candidate. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2432 / 2439
页数:8
相关论文
共 29 条
[1]  
Bailey N, 1975, MATH THEORY INFECT D
[2]   Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children [J].
Belshe, RB ;
Newman, FK ;
Anderson, EL ;
Wright, PF ;
Karron, RA ;
Tollefson, S ;
Henderson, FW ;
Meissner, HC ;
Madhi, S ;
Roberton, D ;
Marshall, H ;
Loh, R ;
Sly, P ;
Murphy, B ;
Tatem, JM ;
Randolph, V ;
Hackell, J ;
Gruber, W ;
Tsai, TF .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (12) :2096-2103
[3]   Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old [J].
Belshe, RB ;
Newman, FK ;
Tsai, TF ;
Karron, RA ;
Reisinger, K ;
Roberton, D ;
Marshall, H ;
Schwartz, R ;
King, J ;
Henderson, FW ;
Rodriguez, W ;
Severs, JM ;
Wright, PF ;
Keyserling, H ;
Weinberg, GA ;
Bromberg, K ;
Loh, R ;
Sly, P ;
McIntyre, P ;
Ziegler, JB ;
Hackell, J ;
Deatly, A ;
Georgiu, A ;
Paschalis, M ;
Wu, SL ;
Tatem, JM ;
Murphy, B ;
Anderson, E .
JOURNAL OF INFECTIOUS DISEASES, 2004, 189 (03) :462-470
[4]   COLD ADAPTATION OF PARA-INFLUENZA VIRUS TYPE-3 - INDUCTION OF 3 PHENOTYPIC MARKERS [J].
BELSHE, RB ;
HISSOM, FK .
JOURNAL OF MEDICAL VIROLOGY, 1982, 10 (04) :235-242
[5]   The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children [J].
Belshe, RB ;
Mendelman, PM ;
Treanor, J ;
King, J ;
Gruber, WC ;
Piedra, P ;
Bernstein, DI ;
Hayden, FG ;
Kotloff, K ;
Zangwill, K ;
Iacuzio, D ;
Wolff, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (20) :1405-1412
[6]  
CHANOCK R. M., 1963, AMER REV RESP DIS, V88, P152
[7]  
CHANOCK RM, 2001, FIELDS VIROLOGY, V1, P1341
[8]   EVALUATION OF COLD-ADAPTED AND TEMPERATURE-SENSITIVE MUTANTS OF PARA-INFLUENZA VIRUS TYPE-3 IN WEANLING HAMSTERS [J].
CROOKSHANKS, FK ;
BELSHE, RB .
JOURNAL OF MEDICAL VIROLOGY, 1984, 13 (03) :243-249
[9]   PROTECTION OF WEANLING HAMSTERS FROM EXPERIMENTAL-INFECTION WITH WILD-TYPE PARA-INFLUENZA VIRUS TYPE-3 (PARA-3) BY COLD-ADAPTED MUTANTS OF PARA-3 [J].
CROOKSHANKSNEWMAN, FK ;
BELSHE, RB .
JOURNAL OF MEDICAL VIROLOGY, 1986, 18 (02) :131-137
[10]  
CROWE JE, 1997, NEW GENERATION VACCI, P711